You are using an outdated browser. This site may not function properly with it.
For a better experience, please upgrade to a modern browser here.
VTVT up on positive phase 2 results
VTVT up on good news
VTVT Therapeutics announces positive initial topline results from Phase 2b study of Glucokinase Activator TTP399
VTVT breaking $10 now too, great 25% move so far
VTVT $10. closed some at 9.90
Congrats VTVT longs...approaching PT $10 IPO price soon